BioNTech adds CAR-T manufacturing with $250m Autolus deal February 9, 2024 AutoBot News 0 Germany’s BioNTech has taken a $200 million stake in Autolus in a private placement that will allow it to tap into the UK company’s manufacturing capacity for CAR-T therapies.